- Chemists have
chemically synthesized a short protein fragment that can bind to part of
SARS-CoV-2 spike protein, which could
block the penetration of
the virus into mammalian cells.
- Coronavirus pandemic: BeckmanCoulter is developing tests to identify antibodies to the virus.
- Purdue innovators moving to fast-track COVID-19 diagnostic, therapeutic solutions.
Comments
Post a Comment